Giancarlo Elia Valori, professor, economist and journalist, is the winner of the XXX edition of the Ischia Mediterranean Award. The recognition was awarded "for the acute analysis and original reporting on geopolitical and economic dell'Area - the fruit of direct knowledge developed into successful books and articles in newspapers and magazines with international significance." The jury presided by Alfonso Ruffo and composed by Claudio Azzolini, Francesco Cervelli, Annamaria Chiariello, Giordano Bruno Guerri, Maurizio Maddaloni, Nicola Marrazzo, Angela Riccio, Gennaro Sangiuliano, Antonio Sasso, and Marcello Veneziani ruled at the meeting held in Rome at the headquarters of Vodafone.

ELIA VALORI, PROPOSED BOYCOTT OF JEWISH SHOPS "absurd and perverted strategy"

(Adnkronos) - "On behalf of myself and my Association Israel 60, I would like to express the most intense closeness and solidarity to the Roman Jewish community for the absurd and perverse proposal to boycott the Jewish shops in Roma as protest for what is happening in Gaza," said the president of 'Israel 60', Giancarlo Elia Valori.

Pharma Finance is an international event addressing new technologies for Life Sciences, concentrating on Biotechnology, finance, nano-technology and innovative materials.

The Lazio Region and Sviluppo Lazio S.p.A. jointly organized Pharma Finance, in collaboration with the Ministry for International Commerce, ICE, Filas S.p.A. and the Zangani Investor Community.

Pharma Finance 2008 is the only fully dedicated event in Italy focusing on intellectual property exchanges, licensing, strategic alliance, and marketing.

For more information, please visit www.pharmafinance.net

One of Italy’s most eminent and prominent figures warns that Iran’s budding nuclear weapons program poses an “immediate threat” to the United States, Israel and the West, but that Washington needs to cautiously deal with the problem.

If not, Giancarlo Valori tells Newsmax, the United States could give “rise to power, which will be equally violent and dangerous, of the current opponents of Iran.”

Valori (pictured with Shimon Peres), a noted businessman, professor and economist, notes that if Israel is the key antagonist and policies toward Iran are “shaped by Tel Aviv,” actions against Tehran could imperil relations between the United States and Europe.

Hu Jintao started his political ascent at the top leadership of the Communist Party of China by managing the repression of the demonstrations which took place in Lhasa, Tibet in 1989 . He was selected as Head of the Party in Tibet due to his reputation as “reformer”. After his relations with Jiang Nanxiang, his first supporter in the CCP hierarchy, he was appointed as instructor at the Party School of the Tsinghua University. After the “Great Proletarian Cultural Revolution” which started in 1967, Hu Jintao was sent to the Gansu province for one year and was subsequently assigned to No. 813 Sub-Bureau, Fourth Engineering Bureau, Ministry for Water Conservancy, in charge of water resources and electric energy production.

Prof. Giancarlo Valori has written an enlightening book on the peoples, cultures and civilizations around the Mediterranean – from ancient times to the present – that provide the reader with a sweeping account of the riveting chapters of its history.

There are great expectations in New York for the arrival of Giancarlo Elia Valori, President of Sviluppo del Mediterraneo SpA and Sviluppo Lazio SpA who, on Tuesday evening, will officially take the Chair for Peace at the Rabbi Arthur Schneier Center of International Affairs of the Yeshiva University, the prestigious private university of the American Jewish Community.

PHARMA-FINANCE 2007. ROME 10-11 MAY

By Laura Teodori and Zofia Maciorowski

Rome, the eternal city, alongside its ancient ruins and classic architectural beauties, looks to the future. The title of this first Congress is thus ‘Pharma-Finance 2007 wagering on the future’. Promoted by Sviluppo Lazio (www.sviluppolazio.it) in collaboration with Zangani Investor Community (www.zangani.com) to foster interactions between drugs and biotech, innovative research enterprises and finance, in order to encourage growth opportunities: science, research and behind all this, industry and finance. Pharma-Finance 2007 was an important part of a program of internationalization policies with not just words and ideas but concrete advancement. The goal was to make Italian businesses and Lazio small and medium sized enterprises interact with equivalent US and international pharmaceutical and financial players.

Basically we can say that today in Europe we witness the resurgence of a new anti-Semitism which, after all, shows strong signs of continuity with the traditional Judeophobia.

Statistics show that in 2006 - the last year for which updated and reliable information exist - in Europe about 2,200 violent acts of anti-Semitism were perpetrated against Jews or assets and buildings belonging to the Jewish Community or its members.

In a territorial setting of real productive potential yet to be fully tapped. Sviluppo Lazio must ensure new and important impetus to regional economic dynamics, in order to contribute to the growth of our regions and their characterizing traits.

True impetus may come from new, proven market tactics, which is to say by further promoting the territory's competitiveness with energies and potential to be guided even more decisively through a strategic mix: territorial marketing and internationalization.

Sviluppo Lazio, Lazio's regional development agency, was founded in 1999 and is charged with the task of implementing the region's economic and territorial agendas. In a region so rich with potential, Sviluppo Lazio's primary mission is to assist in the development of regional infrastructures, manufacturing businesses, and to increase employment. The agency accomplishes this mission in many ways: by promoting enterprise motivated ideology; by sustaining territorial development programs; by participating in infrastructural investment projects and by fostering partnerships between public and private entities.